Navigation Links
The Diabetes Series 2008: Experts Speak About Developing Diabetes Therapeutics
Date:2/25/2008

SAN DIEGO, Feb. 25 /PRNewswire/ -- Speid & Associates, a San Diego-based regulatory affairs and drug development consultancy, is hosting a six session Webinar series on diabetes and related metabolic diseases during the months of March and April. Speakers will include former Food and Drug Administration officials Dr. Alexander Fleming and Dr. Ray Lipicky, as well as a distinguished list of other guest speakers and panelists.

Researchers and companies involved in diabetes therapeutic development are finding a complex array of possible targets across diabetes (both type 1, type 2), the metabolic syndrome, and the complications and causes of diabetes. This translates into a complex pathway for therapeutic development and registration with many potential pitfalls along the way. The webinar series will promote discussion on the inter-related issues of diabetes/metabolic therapeutic development and registration.

Dr. Speid said, "I am delighted that the series will feature such a stellar list of speakers, to address these important topics and issues." Dr. Alexander Fleming, ex-FDA (formerly headed diabetes drug review) said, "There is no more active and controversial therapeutic development area than for diabetes drugs. I look forward to discussing the implications of the ACCORD trial and a number of other timely topics."

For many years, Dr. Ray Lipicky headed FDA's Division of Cardiorenal Drug Products. Among his many drug approvals was the first and essentially only approval of treatments for a diabetic complication. The participation of Drs. Lipicky and Fleming in this series mirrors the convergence of cardiovascular and metabolic therapeutics at multiple levels -- pathophysiology, drug targets, trial design, and clinical disciplines.

Speid & Associates, Inc. is a regulatory affairs and drug development consultancy based in San Diego, Calif. The firm, founded in 2004 by Dr. Lorna Speid, Ph.D., assists life science companies at various
'/>"/>

SOURCE Speid & Associates, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Vaccines are Likely to Cause Insulin Dependent Diabetes in Over 2% of Children With a Strong Family History of Insulin Dependent Diabetes, New Data Indicates
2. Good Neighbor Pharmacy(R) Ironman Competitor Inspires Individuals with Diabetes to Live Without Limits
3. Genaera Corporation to Participate in Diabetes and Obesity Panel at RBC Capital Markets Healthcare Conference
4. GlaxoSmithKline Responds to JAMA Article on the ICES Thiazolidinediones and Cardiovascular Outcomes in Older Patients with Diabetes
5. Novo Nordisk Applauds Adoption of World Diabetes Day Resolutions by U.S. Congress
6. International Diabetes Experts Call for Stepped-Up Action and Shared Responsibility to Curb Rising Global Diabetes Epidemic and Impact
7. World Think Tank on Type 1 Diabetes Meets in Miami
8. New Web Site Tools Help Alleviate Stress Associated with Caring for Children with Diabetes During the Holidays
9. Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes
10. SemBioSys to present insulin data at the Seventh Annual Diabetes Technology Meeting
11. John Timberlake, Valeritas Executive Vice President and General Manager, Named Executive of the Year by the Diabetes Foundation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... July 30, 2015 Sanofi, ... publie ses résultats pour le premier semestre 2015. ... les résultats. Visionner l,interview vidéo et ... Au sommaire de l,interview :  ... Moteurs de croissance - Diabète ...
(Date:7/29/2015)... (Q2 2015: +14% CER / 20% of sales) led the regional performance in ... , as well as solid contributions from Korea, India ... Middle East / Africa (Q2 2015: ... , Turkey and the United Kingdom ... excluding U.S. HPV sales, on demand across all customer classes. The top seven ...
(Date:7/29/2015)... July 29, 2015  AsureQuality and Ubiquitome have ... for applications in food and primary production sectors. ... real-time PCR device, the Freedom4. AsureQuality ... to the supermarket shelf for producers, processors and ... in animal disease control and pest management and ...
(Date:7/29/2015)... MILWAUKEE, Wis. (PRWEB) , ... July 29, 2015 ... ... facility identification solutions, today announced its GHS Label Guide . To align ... Harmonized System (GHS), this guide includes explanations of label components, an example of ...
Breaking Biology Technology:QIAGEN Reports Results for Second Quarter and First Half of 2015 2QIAGEN Reports Results for Second Quarter and First Half of 2015 3QIAGEN Reports Results for Second Quarter and First Half of 2015 4QIAGEN Reports Results for Second Quarter and First Half of 2015 5QIAGEN Reports Results for Second Quarter and First Half of 2015 6QIAGEN Reports Results for Second Quarter and First Half of 2015 7QIAGEN Reports Results for Second Quarter and First Half of 2015 8QIAGEN Reports Results for Second Quarter and First Half of 2015 9QIAGEN Reports Results for Second Quarter and First Half of 2015 10AsureQuality and Ubiquitome Partner on Applications for Mobile Molecular Food Safety Testing 2Brady Announces a New GHS Label Guide 2
... Texas, Dec. 21 Lexicon,Pharmaceuticals, Inc. (Nasdaq: ... investigational new drug (IND) application to the U.S. ... drug candidate for managing,gastrointestinal symptoms associated with carcinoid ... is planned as a double-blind, randomized,placebo-controlled, ascending single-dose ...
... MALVERN, Pa., Dec. 21 Solstice Neurosciences, Inc.,("Solstice") ... President and,Chief Executive Officer. He will also continue ... Mr. Smith brings unique specialty pharmaceutical industry ... in providing guidance,leadership, and strategies for growth as ...
... ROCK, Colo., Dec. 20 AspenBio Pharma,Inc. (Nasdaq: ... to the,development of novel drugs and diagnostics for ... into securities purchase agreements in,connection with a private ... Under the terms of the agreement, AspenBio will ...
Cached Biology Technology:Lexicon Files Investigational New Drug Application for LX1032 as a Potential Treatment for Carcinoid Syndrome 2Lexicon Files Investigational New Drug Application for LX1032 as a Potential Treatment for Carcinoid Syndrome 3Dennis L. Smith Appointed President and Chief Executive Officer of Solstice Neurosciences, Inc. 2AspenBio Pharma Announces $18 Million Private Placement of Common Stock 2AspenBio Pharma Announces $18 Million Private Placement of Common Stock 3
(Date:7/7/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") ... announces a revised version of one of its first 30 second ... CNBC in New York , Chicago ... San Francisco metro areas.    , , ... replace all the cards in your wallet and keep your identity ...
(Date:7/2/2015)... , July 2, 2015 Fingerprint ... FPC1025, FPC1035, FPC1145 and FPC1155 from the distributor World Peace ... of FPC,s distributors in Asia . Deliveries ... The sensors will be used by smartphone manufacturers in ... is included in the communicated revenue guidance of approximately 2,200 ...
(Date:6/29/2015)... 24, 2015 Research and ... "Latin America Biomedical Sensors Market - Growth, Trends ... The Latin America Biomedical Sensors market is estimated ... 2.04% over the period 2014-2020 The near ... the genetic formulation of each individual. These sensors can ...
Breaking Biology News(10 mins):Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2Latin America Biomedical Sensors Market Report 2015-2020 2
... 16, 2013 With its fingerprint-identity sensor, Apple,s new ... mobile devices.  Unfortunately, it didn,t take long for hackers ... 5S, but software from an upstate New ... – safeguards users, devices against such vulnerabilities. ...
... NEW YORK , Oct. 17, 2013 /PRNewswire-iReach/ -- ... and personalized medicine, is pleased to announce the deployment of ... based on its proprietary cloud-based biomedical engine, Cliniscan ... Cliniscan TM , the ...
... Babcock Genetics, Inc., a worldwide supplier of swine genetics, announces ... genetic program available to swine producers. "Babcock ... offer a higher level of profitability to our customers." said ... are maximizing genetic improvement by selecting lines that best complement ...
Cached Biology News:NexID Biometrics: The Solution to Spoofing Mobile Biometrics 2NexID Biometrics: The Solution to Spoofing Mobile Biometrics 3Picofemto Deploys Cloud-Based Cliniscan EEG Analytics and Clinical Decision Support 2Picofemto Deploys Cloud-Based Cliniscan EEG Analytics and Clinical Decision Support 3
8.1.1...
Human SCP3 Affinity Purified Polyclonal Ab Keywords: Spermatogenesis, meiosis Protein Family: Cell Cycle...
... and efficient purification of DNA and oligonucleotides ... by gravity flow.Prepacked with Sephadex G-25 DNA ... CG/ICP Biocide.Available in three sizes depending on ... ml (NAP-10) or 2.5 ml (NAP-25).Useful for ...
Homo sapiens alcohol dehydrogenase 5 (class III), chi polypeptide (ADH5), mRNA....
Biology Products: